KMID : 1023520230460030181
|
|
Korean Journal of Veterinary Service 2023 Volume.46 No. 3 p.181 ~ p.192
|
|
Cystatin C for managing diuretic-induced kidney dysfunction in MMVD dogs
|
|
Han Dong-Hyun
Cho Jae-Hyeon Kim Chung-Hui
|
|
Abstract
|
|
|
Cystatin C, a low-molecular-weight protein synthesized by cells, is being explored as a valuable biomarker for assessing renal function in veterinary medicine. Although the relationship between cystatin C and heart disease remains unclear, some studies suggest a possible association. This retrospective case-control study aimed to investigate the role of cystatin C as a biomarker for heart disease and its correlation with diuretic use in veterinary clinical practice. A total of 39 dogs were included in this study, comprising 9 control dogs without a predisposition to heart disease and 30 dogs in the study group diagnosed with heart disease. Among the 30 dogs with heart disease, 18 exhibited symptoms indicative of heart failure. Results showed significantly higher cystatin C levels in the heart disease group compared to the control group (P<0.05). However, no significant differences were observed among different stages of heart disease severity in the control group. Furthermore, cystatin-C showed statistically positive correlations with BUN (r=0.478, P<0.01), creatinine (r=0.506, P<0.01), and furosemide (r=0.338, P<0.05). Diuretics are essential for managing congestive heart failure, and the observed associations between cystatin C and furosemide suggest potential impacts of diuretic use on renal function in dogs with heart failure. Monitoring renal function markers, such as cystatin C, can aid in predicting and managing potential renal complications, ultimately improving the overall health and quality of life of dogs with heart disease.
|
|
KEYWORD
|
|
Cystatin C, Heart failure, Renal dysfunction, Furosemide, Dog
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|